Home > Articles posted by News Desk (Page 45)
FEATURE
on Jul 29, 2025
253 views 2 mins

NewAge Industries, Inc., a leader in the design, manufacture, and distribution of fluid transfer systems, has announced the addition of two seasoned professionals to its leadership team. Mark Thornton, MBA, joins as a Board Member, bringing over twenty-five years of experience in the biopharma industry. His expertise in transformational global leadership and strategic vision is […]

FEATURE
on Jul 29, 2025
320 views 2 mins

HR.com, recognized as the largest global community for HR professionals, has announced a strategic partnership with Graphio.ai, an AI-powered analytics platform. This collaboration aims to redefine how organizations understand and optimize their workforce processes and talent flow. By integrating Graphio.ai’s technology, HR.com is pioneering a new approach to workforce intelligence, enabling real-time corporate health checks […]

FEATURE
on Jul 29, 2025
235 views 2 mins

SEGG Media Corporation (NASDAQ: SEGG, LTRYW), a leader in the intersection of sports, entertainment, and gaming technology, has announced a pivotal five-year, $11.6 million commercial agreement with Super League Kerala (SLK). This partnership represents SEGG Media’s inaugural football league collaboration in India, signaling a strategic expansion into the country’s burgeoning sports market. The agreement, finalized […]

FEATURE
on Jul 29, 2025
247 views 2 mins

GeoVax Labs, Inc. has underscored the strategic and commercial importance of the European Medicines Agency’s (EMA) recent positive Scientific Advice regarding its GEO-MVA vaccine for Mpox and smallpox. This regulatory feedback suggests that a single Phase 3 immuno-bridging trial could suffice for a Marketing Authorization Application in the EU, significantly shortening the development timeline and […]

FEATURE
on Jul 29, 2025
241 views 2 mins

AlgoFusion 5.0 has launched a strategy grading engine that transforms how traders evaluate and refine their trading systems. This innovative tool offers a comprehensive framework for assessing strategy quality through real-time performance scoring and objective diagnostics. By focusing on statistical accuracy, behavioral consistency, and structural integrity, the engine provides a transparent method for users to […]

FEATURE
on Jul 29, 2025
252 views 2 mins

ONAR Holding Corp. (OTCQB: ONAR) has announced the appointment of Scott Kauffman, the former Chairman and CEO of MDC Partners, as the new Chairman of its Board of Directors. This strategic decision underscores ONAR’s commitment to scaling its marketing technology platform for mid-sized brands and broadening its global agency network through both organic growth and […]

FEATURE
on Jul 29, 2025
254 views 2 mins

Gold’s price surge beyond $3,300 per ounce in 2025 underscores a growing investor skepticism towards the global financial system, with inflation and waning confidence in fiat currencies driving gold’s reemergence as a reliable store of value. This shift has notably increased investments in Canadian gold ventures, especially those operating within the Abitibi Greenstone Belt, Canada’s […]

FEATURE
on Jul 29, 2025
246 views 57 secs

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) has officially started its summer field program at the Gochager Lake Project in Saskatchewan, marking a significant step in its exploration efforts. The program, initially delayed due to regional wildfires, is now underway with a geological crew mobilized to the site. Preparatory work, including the completion […]

FEATURE
on Jul 29, 2025
230 views 2 mins

Royalty Management Holding Corporation (Nasdaq: RMCO) is making significant strides in the rare earth and critical mineral sectors through targeted investments in companies like Advanced Magnet Lab, Inc. (AML), NeoRe SpA, and ReElement Technologies. These investments aim to create a comprehensive ‘mine-to-magnet’ industry within the United States and allied countries, challenging China’s dominant position in […]

FEATURE
on Jul 29, 2025
361 views 2 mins

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage developer of broad-spectrum antivirals, has announced promising results for its lead drug candidate, NV-387, in the treatment of Measles. The drug demonstrated a significant increase in survival rates in a lethal respiratory infection model using humanized mice, with survival times extending from 7.4 to 17 days, marking a […]